Half of the 2021 Nobel Prize in Medicine went to David Julius, PhD, professor in the Department of Physiology at the University of California, San Francisco (UCSF). The scientist received the prize for his research on so-called TRP ion channels. The award evoked enthusiasm (also) among some of our colleagues. Questions to Dr. Dirk Sombroek, Unit Head, BioActives & Performance Biologicals at BRAIN Biotech.
At EFIB 2021, representatives from business and politics finally met again in-person, where biotechnology as a driver of the bioeconomy and the hope for an early amendment of the European genetic engineering law was discussed.
Biocatalysts has brought a new enzyme production facility on stream in a very short time, despite pandemic-related difficulties. Craig Galeozzie, Operations Director at Biocatalysts Ltd., reports on this experience.
